CoChat

The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast Carcinomas

Open access
Verlinden, Lieve, Vanden Bempt, Isabelle, Eelen, Guy, Drijkoningen, Maria, Verlinden, Ilse, Marchal, Kathleen, De Wolf-Peeters, Christiane, Christiaens, Marie-Rose, Michiels, Luc, Bouillon, Roger, Verstuyf, Annemieke · 2007 · Cancer Research
Cited by 146

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

We previously showed that checkpoint kinase 1 (Chk1) and Claspin, two DNA-damage checkpoint proteins, were down-regulated by 1,25-dihydroxyvitamin D3, a known inhibitor of cell proliferation. In the present study, we aimed to investigate the transcriptional regulation of Chk1 and Claspin and to study their expression levels in human breast cancer tissue. Transient transfection experiments in MCF-7 breast cancer cells showed that promoter activities of Chk1 and Claspin were regulated by the E2F family of transcription factors. Subsequently, transcript levels of Chk1, Claspin, and E2F1 were determined by quantitative reverse transcriptase-PCR analysis in 103 primary invasive breast carcinomas and were compared with several clinicopathologic variables in breast cancer. A strong correlation was found between Chk1 and Claspin transcript levels. Transcript levels of Chk1, Claspin, and E2F1 were highest in histologic grade 3 tumors and in tumors in which the expression of estrogen receptor (ER) and progesterone receptor (PR) was lost. Moreover, Chk1 expression was significantly elevated in grade 3 breast carcinomas showing a triple-negative ER−/PR−/HER-2− phenotype compared with other grade 3 tumors. Further research is warranted to validate the use of Chk1 inhibitors in triple-negative breast carcinomas for which treatment strategies are limited at present. [Cancer Res 2007;67(14):6574–81]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-3545

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Cell-cycle checkpoints and cancer

    Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · cited 1×

    “Activated Chk1 inhibits Cdc25 phosphatases, which control inhibitory phosphorylation sites on cyclin-dependent kinases, the latter being critical regulators of cell cycle transitions (2).”
    Background
  • Common markers of proliferation

    Whitfield, M. L., George, L. K., Grant, G. D., & Perou, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1802 · Cited by 650 · cited 2×

    “To this end, a new generation of oncolytic adenoviral vectors, expressing antisense Chk1 cDNA preferentially in tumor cells, has been used in a preclinical setting and yielded promising results (6, 23).”
    Background
  • Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation

    Lin, S.-Y., Li, K., Stewart, G. S., & Elledge, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401847101 · Cited by 156 · cited 1×

    “Moreover, Claspin is shown to be involved in cell proliferation as overproduction of Claspin stimulates cell growth, suggesting an oncogenic role for Claspin (5).”
    Background

Show all 3 references

Cited by

See all 146

Metadata

Authors
Verlinden, L., Vanden Bempt, I., Eelen, G., Drijkoningen, M., Verlinden, I., Marchal, K., De Wolf-Peeters, C., Christiaens, M.-R., Michiels, L., Bouillon, R., & Verstuyf, A.
Venue
Cancer Research
Published
2007-07-15
Volume
67
Issue
14
Pages
6574-6581
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2134493631
Cited by
146
References
3
FWCI
2.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast Carcinomas. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-3545
The paper
Verlinden, L., Vanden Bempt, I., Eelen, G., Drijkoningen, M., Verlinden, I., Marchal, K., De Wolf-Peeters, C., Christiaens, M.-R., Michiels, L., Bouillon, R., & Verstuyf, A. (2007). The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor−/Progesterone Receptor−/HER-2− Breast Carcinomas. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-3545

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.